# Boston Scientific Closes $14.5 Billion Penumbra Acquisition, Strengthening Neurovascular Leadership

> ma · REPORTED · 2026-06-12

Boston Scientific's $14.5 billion acquisition of Penumbra, a maker of thrombectomy and embolization devices for stroke and peripheral vascular disease, was tracked as completed and the subject of analyst commentary in June 2026, with the deal significantly expanding Boston Scientific's neurovascular and interventional device portfolio and representing the year's largest medtech transaction.

- Company: Boston Scientific / Penumbra
- Sector: medical devices
- Primary source: https://www.medtechdive.com/topic/ma/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.